Medical Health & Life Science Research News

Research details developments in the influenza vaccines industry

Research details developments in the influenza vaccines industry

This research report titled "Americas Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2021" provides a comprehensive analysis of the fast-evolving influenza vaccines market. This 90 Page report contains 33 Figures and 8 Tables to present a clear picture of the influenza vaccines market landscape.

- Agency -.

Complete report available at www.marketreportsonline.com/545524.html.

Influenza Vaccines Brand Sales and Forecast - 7 Brands Analyzed: Fluarix/FluLaval, Fluzone, Fluvirin/Flucelvax, Influvac, Afluria/Fluvax & Flublok

Country Coverage: United States, Canada, Brazil & Mexico

The influenza vaccines market in Americas is anticipated to reach nearly US$ 3 Billion by 2021.

- Agency -.

Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly.

Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, rising government support for immunization and growing awareness of the value of influenza vaccine in preventing disease are the prominent factors that will fuel the growth of the influenza vaccines market.

In the Americas, United States captures majority of the influenza vaccines market share. Brazil is the second leading market for influenza vaccines with around XX% share in 2015.

Canada and Mexico are the third and fourth leading market for influenza vaccines with XX% and XX% market share respectively in 2015.

In the influenza vaccines brand sales segment, Sanofi's Fluzone holds the maximum share of the market being followed by Fluvirin/Flucelvax. GSK's Fluarix/FluLaval accounts for the third highest share of the influenza vaccines market.

FluMist/Fluenz and Afluria/Fluvax stands at the fourth and fifth position in the influenza vaccines market, while Flublok has captured least share of the influenza vaccines market.

Report at http://www.marketreportsonline.com/contacts/545524.

Few Points from List of Figures:

Figure 2-1: Americas - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 2-2: Americas - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 2-3: Americas - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 2-4: Americas - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-1: United States - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-2: United States - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-3: United States - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-4: United States - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-5: Canada - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-6: Canada - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-7: Canada - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-8: Canada - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-9: Brazil - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-10: Brazil - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021

 

News From

MarketReportsOnline - Industry Research Analysis StoreMarketReportsOnline
Category: Market Research Publishers and RetailersCompany profile: MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.